CD4 and diffuse large B-cell lymphoma: This study aims to investigate the relationship between lymphocyte subsets and prognosis in DLBCL patients, assess the potential of the CD4+/CD8+ ratio as an immunological prognostic marker, and further reveal the connection between the immune system and treatment outcomes.